Tirzepatide + NAD⁺ + Glutathione

Redox-Regulated Dual Incretin Recovery Stack

Mechanistic Synergy for Research:

• Glutathione (GSH) protects pancreatic beta cells and vascular endothelium against oxidative stress, which are vulnerable in hyperglycemic models.
• Tirzepatide reduces systemic glycotoxicity; NAD⁺ and GSH protect mitochondrial and DNA integrity under inflammatory load.

Combined Benefits:

• Preserves insulin receptor function and intracellular glucose signaling.
• Enhances tissue responsiveness by maintaining NAD⁺/GSH redox cycles.

Use Cases:
Oxidative stress models, high-fat diet–induced insulin resistance, redox-linked metabolic disorders.